Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,310 | 41,160 | 48,200 | 50,620 | 38,150 |
| Marketable Securities | 1,960 | 1,970 | 1,990 | 3,660 | 3,500 |
| Receivables | 50 | 70 | 50 | 70 | 270 |
| Other current assets | 740 | 560 | 870 | 400 | 280 |
| TOTAL | $36,060 | $43,760 | $51,110 | $54,750 | $42,200 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 740 | 710 |
| TOTAL | $N/A | $N/A | $N/A | $740 | $710 |
| Total Assets | $36,450 | $44,030 | $51,350 | $55,720 | $43,140 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,580 | 3,550 | 4,320 | 2,370 | 2,420 |
| TOTAL | $6,580 | $3,550 | $4,320 | $2,370 | $2,420 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,580 | $3,550 | $4,320 | $2,370 | $2,420 |
| Shareholders' Equity | |||||
| Common Shares | 179,410 | 181,290 | 183,110 | 179,660 | 150,720 |
| Retained earnings | -173,490 | -163,420 | -158,670 | -148,440 | -134,730 |
| Other shareholders' equity | 2,560 | 2,590 | 2,540 | 2,490 | 5,890 |
| TOTAL | $29,870 | $40,480 | $47,020 | $53,350 | $40,710 |
| Total Liabilities And Equity | $36,450 | $44,030 | $51,340 | $55,720 | $43,130 |